Market Tracker

09/30 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

6.35
Delayed Data
As of Sep 30
 +0.09 / +1.44%
Today’s Change
4.39
Today|||52-Week Range
10.85
-19.62%
Year-to-Date
Bullish and Bearish Reversals for the Week
Sep 26 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.26
Today’s open6.30
Day’s range6.20 - 6.48
Volume3,279,464
Average volume (3 months)2,178,452
Market cap$820.7M
Dividend yield--
Data as of 4:14pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+18.14%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.39+3.24%
CLLSCellectis SA+0.01+0.04%
INSYINSYS Therapeutics I...-0.29-2.40%
AMPHAmphastar Pharmaceut...+0.13+0.69%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts